medline.ch Onkologie

	The Efficacy of Exercise in Reducing Depressive Symptoms among Cancer Survivors: A Meta-Analysis. PLoS One. Brown JC, Huedo-Medina TB, Pescatello LS, Ryan SM, Pescatello SM, Moker E, Lacroix JM, Ferrer RA, Johnson BT. PMID: 22303474 [PubMed - in process]
	Portable optical fiber probe-based spectroscopic scanner for rapid cancer diagnosis: a new tool for intraoperative margin assessment. PLoS One. Lue N, Kang JW, Yu CC, Barman I, Dingari NC, Feld MS, Dasari RR, Fitzmaurice M. PMID: 22303465 [PubMed - in process]
	Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models. PLoS One. Shen L, Ciesielski M, Ramakrishnan S, Miles KM, Ellis L, Sotomayor P, Shrikant P, Fenstermaker R, Pili R. PMID: 22303460 [PubMed - in process]
	PAX Genes in Cancer; Friends or Foes? Front Genet. Li CG, Eccles MR. PMID: 22303411 [PubMed - in process]
	Epitope-based immunoinformatics and molecular docking studies of nucleocapsid protein and ovarian tumor domain of crimean-congo hemorrhagic Fever virus. Front Genet. Srinivasan P, Kumar SP, Karthikeyan M, Jeyakanthan J, Jasrai YT, Pandya HA, Rawal RM, Patel SK. PMID: 22303367 [PubMed - in process]
	Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results. J Nucl Med. Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E. PMID: 22302962 [PubMed - in process]
	Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis. J Nucl Med. Dunet V, Rossier C, Buck A, Stupp R, Prior JO. PMID: 22302961 [PubMed - in process]
	Population-based survival for childhood cancer patients diagnosed during 2002-2005 in Shanghai, China. Pediatr Blood Cancer. Bao PP, Zheng Y, Wu CX, Peng P, Gong YM, Huang ZZ, Fan W. PMID: 22302759 [PubMed - as supplied by publisher]
	Clinical value of endosonography in the assessment of laryngeal cancer. Head Neck. Kraft M, Bruns N, Hügens-Penzel M, Arens C. PMID: 22302678 [PubMed - as supplied by publisher]
	Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy. Breast Cancer. Honma N, Horii R, Iwase T, Saji S, Younes M, Ito Y, Akiyama F. PMID: 22302643 [PubMed - as supplied by publisher]
	Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study. Tumour Biol. Fan C, Lin X, Wang E. PMID: 22302483 [PubMed - as supplied by publisher]
	Assessing health-related quality of life of Chinese-American breast cancer survivors: a measurement validation study. Psychooncology. Ashing-Giwa K, Lam CN, Xie B. PMID: 22302455 [PubMed - as supplied by publisher]
	Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index. Cancer Chemother Pharmacol. Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA. PMID: 22302409 [PubMed - as supplied by publisher]
	RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer. Cancer Chemother Pharmacol. Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Wang Y, Shentu JZ. PMID: 22302408 [PubMed - as supplied by publisher]
	ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis. Mol Biol Rep. Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q. PMID: 22302397 [PubMed - as supplied by publisher]
	A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer. Invest New Drugs. Hwang IG, Jang JS, Oh SY, Lee S, Kwon HC, Lee GW, Go S, Kang MH, Cha YJ, Kang JH. PMID: 22302349 [PubMed - as supplied by publisher]
	Combined Diffusion-Weighted and Gadolinium-Enhanced MRI Can Accurately Predict the Peritoneal Cancer Index Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures. Ann Surg Oncol. Low RN, Barone RM. PMID: 22302265 [PubMed - as supplied by publisher]
	The Relationship of Lymph Node Evaluation and Colorectal Cancer Survival After Curative Resection: A Multi-Institutional Study. Ann Surg Oncol. Kanemitsu Y, Komori K, Ishiguro S, Watanabe T, Sugihara K. PMID: 22302263 [PubMed - as supplied by publisher]
	Diabetes Mellitus Is an Independent Risk Factor for Colorectal Cancer. Dig Dis Sci. Sun L, Yu S. PMID: 22302244 [PubMed - as supplied by publisher]
	Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer. Oncologist. Hedden L, O'Reilly S, Lohrisch C, Chia S, Speers C, Kovacic L, Taylor S, Peacock S. PMID: 22302231 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 815083

Seite 1 von 40755

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG Alfred Escher-Strasse 36 8002 Zürich Tel.: +41 (0)44 204 16 77 Fax: +41 (0)44 204 16 70
	Disclaimer \| Privacy Policy